CAPELLO, Michela
 Distribuzione geografica
Continente #
NA - Nord America 3.127
EU - Europa 1.632
AS - Asia 1.424
SA - Sud America 135
AF - Africa 51
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.413
Nazione #
US - Stati Uniti d'America 3.092
CN - Cina 567
SG - Singapore 525
IT - Italia 270
DK - Danimarca 237
SE - Svezia 222
DE - Germania 136
IE - Irlanda 136
AT - Austria 123
BR - Brasile 117
UA - Ucraina 109
FI - Finlandia 98
FR - Francia 85
VN - Vietnam 70
GB - Regno Unito 65
KR - Corea 55
PL - Polonia 51
TW - Taiwan 49
SN - Senegal 37
AU - Australia 35
IN - India 29
HK - Hong Kong 27
JP - Giappone 26
CA - Canada 23
NL - Olanda 22
BE - Belgio 19
RU - Federazione Russa 18
ID - Indonesia 17
UZ - Uzbekistan 12
BY - Bielorussia 11
TR - Turchia 9
IQ - Iraq 8
ZA - Sudafrica 8
EU - Europa 7
MX - Messico 7
PK - Pakistan 6
RO - Romania 6
BD - Bangladesh 5
ES - Italia 5
AR - Argentina 4
CL - Cile 4
CZ - Repubblica Ceca 4
CH - Svizzera 3
PH - Filippine 3
BN - Brunei Darussalam 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
GR - Grecia 2
IL - Israele 2
NI - Nicaragua 2
PE - Perù 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
BT - Bhutan 1
CV - Capo Verde 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.413
Città #
Chandler 400
Ann Arbor 322
Beijing 289
Singapore 255
Ashburn 222
Wilmington 147
Houston 137
Dearborn 135
Dublin 135
Santa Clara 123
Vienna 122
Fairfield 114
Nyköping 83
Jacksonville 80
Woodbridge 70
Guangzhou 64
Seattle 60
Cambridge 50
Medford 48
Warsaw 46
Villeurbanne 45
Princeton 44
Torino 44
Fremont 40
Columbus 36
Taipei 35
Los Angeles 33
Pisa 32
Turin 31
Dallas 30
Redwood City 27
Munich 26
Boardman 25
Dong Ket 24
Shanghai 23
Hong Kong 20
Brussels 18
Buffalo 18
Ho Chi Minh City 17
Norwalk 17
Boston 16
San Mateo 16
Washington 16
Nanjing 15
Phoenix 15
Chengdu 13
Turku 13
Jakarta 12
Helsinki 11
Milan 11
Nuremberg 11
London 10
New York 10
Wayne 10
Wuhan 10
Melbourne 9
Shenyang 9
Tokyo 9
Toronto 9
Falls Church 8
San Diego 8
Seoul 8
Zhengzhou 8
Halmstad 7
Hanoi 7
Lincoln 7
Provo 7
Amsterdam 6
Falkenstein 6
Frankfurt am Main 6
Heidelberg 6
Paris 6
Changchun 5
Düsseldorf 5
Hefei 5
Ichikawa 5
Jinan 5
Kunming 5
Monash 5
Mumbai 5
Naples 5
New Taipei 5
Piemonte 5
Polska 5
Silver Spring 5
São Paulo 5
Volpago Del Montello 5
Xian 5
Brooklyn 4
Chicago 4
Clayton 4
Fuzhou 4
Haiphong 4
Johannesburg 4
Lahore 4
Manchester 4
Montreal 4
North Bergen 4
Redondo Beach 4
Tappahannock 4
Totale 3.930
Nome #
Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. 479
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers 362
Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation. 341
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 341
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest 265
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients 261
α-enolase: a promising therapeutic and diagnostic tumor target 259
Chemotherapy effects on immune-complexes in pancreatic ductal adenocarcinoma patients serum 258
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 227
Proteomic data analysis of pancreatic cancer patient sera revealed how chemotherapy shapes the immunogenicity of developing tumors 224
An integrative transcriptomic analysis of glycolytic genes reveals distinct metabolic subtypes in pancreatic cancer 206
Three are better than one: plasminogen receptors as cancer theranostic targets. 180
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 162
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 160
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 150
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 149
Autoantibody signature in human ductal pancreatic adenocarcinoma 148
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 146
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia 139
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 137
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA 132
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 131
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 120
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 120
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 116
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 114
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 111
Towards pancreatic cancer diagnosis using EIS biochips. 106
Serological proteome analysis (SERPA) as a tool for the identification of tumor antigens capable of eliciting immune responses in chronic lymphocytic leukemia (CLL) 106
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis (SERPA) 102
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA 98
QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION (QCM-D) AS TOOL TO EXPLOIT ANTIGEN-ANTIBODY INTERACTIONS IN PANCREATIC DUCTAL ADENOCARCINOMA DETECTION 97
PHOSPHOPROTEOMIC ANALYSIS OF PANCREATIC DUCTAL ADENOCARCINOMA CELLS REVEALS DIFFERENTIAL PHOSPHORYLATION OF CELL ADHESION, CELL JUNCTION AND STRUCTURAL PROTEINS 96
A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma 92
Mass spectrometry analysis reveals novel O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells 91
Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells. 80
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells 76
Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells 73
Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations. 72
Procedimento e kit per la diagnosi in vitro dell’adenocarcinoma duttale pancreatico o per determinare la predisposizione all’adenocarcinoma duttale pancreatico 71
Totale 6.598
Categoria #
all - tutte 18.058
article - articoli 0
book - libri 0
conference - conferenze 7.689
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021495 0 0 0 0 77 67 55 49 64 49 61 73
2021/2022608 20 17 18 35 22 35 57 32 23 58 168 123
2022/2023946 80 98 17 131 92 216 50 73 109 20 40 20
2023/2024334 62 51 30 20 10 57 4 29 2 12 19 38
2024/2025890 13 29 32 95 212 61 27 46 118 48 71 138
2025/2026642 218 48 91 163 122 0 0 0 0 0 0 0
Totale 6.598